Legal Representation
Attorney
Barry L. Kelmachter
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description |
|---|---|---|---|
| Apr 8, 2013 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Apr 6, 2013 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Sep 1, 2012 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Sep 1, 2012 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Sep 1, 2012 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 25, 2012 | DOCK | D | ASSIGNED TO EXAMINER |
| May 14, 2012 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| May 8, 2012 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations being or containing Factor X, also known as thrombokinase, for use in the treatment of blood clotting disorders
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO